Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm.
作者信息
Mossad Sherif Beniameen
机构信息
Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA.
出版信息
Am J Transplant. 2021 Aug;21(8):2908. doi: 10.1111/ajt.16687. Epub 2021 Jun 4.
Abstract
摘要
相似文献
1
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm.未接触过病毒的肾移植受者对mRNA新冠病毒BNT162b2疫苗的体液免疫反应降低：无需惊慌。
Am J Transplant. 2021 Aug;21(8):2908. doi: 10.1111/ajt.16687. Epub 2021 Jun 4.
2
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely.未接触过病毒的肾移植受者对SARS-CoV-2 mRNA疫苗BNT162b2的体液反应降低：虽不令人恐慌，但应予以高度重视。
Am J Transplant. 2021 Aug;21(8):2909. doi: 10.1111/ajt.16710. Epub 2021 Jun 18.
3
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。
Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.
4
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.肾移植受者在未接触过病毒的情况下，对 mRNA SARS-CoV-2 BNT162b2 疫苗的体液反应降低。
Am J Transplant. 2021 Aug;21(8):2719-2726. doi: 10.1111/ajt.16615. Epub 2021 May 7.
5
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.移植前接种疫苗的肾移植受者对 SARS-CoV-2 疫苗保持优越的体液反应。
Clin Transplant. 2021 Dec;35(12):e14478. doi: 10.1111/ctr.14478. Epub 2021 Sep 29.
6
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.肾移植受者对 SARS-CoV-2 mRNA 疫苗的抗体反应：一项前瞻性队列研究。
Clin Microbiol Infect. 2021 Aug;27(8):1173.e1-1173.e4. doi: 10.1016/j.cmi.2021.04.028. Epub 2021 May 3.
7
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
8
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.肾移植受者接种第三剂 SARS-CoV-2 疫苗后的体液免疫反应。
Transplant Proc. 2022 Jul-Aug;54(6):1439-1445. doi: 10.1016/j.transproceed.2022.02.011. Epub 2022 Mar 1.
9
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.肾移植受者对第三剂SARS-CoV-2 mRNA BNT162b2疫苗的抗体和T细胞反应。
Kidney Int. 2021 Dec;100(6):1337-1340. doi: 10.1016/j.kint.2021.09.014. Epub 2021 Oct 4.
10
Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BNT162b2疫苗在实体器官移植受者中的免疫原性。
Am J Transplant. 2021 Aug;21(8):2913-2915. doi: 10.1111/ajt.16607. Epub 2021 May 7.
引用本文的文献
1
A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants.奥密克戎变异株感染 HIV 或实体器官移植后免疫抑制患者的临床特征和管理综述。
Front Public Health. 2024 Feb 22;12:1327093. doi: 10.3389/fpubh.2024.1327093. eCollection 2024.
2
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations.肠道微生物群与提高新冠疫苗接种效果
J Funct Foods. 2021 Dec;87:104850. doi: 10.1016/j.jff.2021.104850. Epub 2021 Nov 10.
3
Ethical review of COVID-19 vaccination requirements for transplant center staff and patients.伦理审查 COVID-19 疫苗接种要求，适用于移植中心工作人员和患者。
Am J Transplant. 2022 Feb;22(2):371-380. doi: 10.1111/ajt.16878. Epub 2021 Nov 15.
4
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely.未接触过病毒的肾移植受者对SARS-CoV-2 mRNA疫苗BNT162b2的体液反应降低：虽不令人恐慌，但应予以高度重视。
Am J Transplant. 2021 Aug;21(8):2909. doi: 10.1111/ajt.16710. Epub 2021 Jun 18.
本文引用的文献
1
Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.无症状 SARS-CoV-2 携带者和有症状/症状前 COVID-19 患者的流行病学特征、病毒脱落和抗体血清转换。
J Infect Public Health. 2021 Jul;14(7):845-851. doi: 10.1016/j.jiph.2021.05.003. Epub 2021 May 27.
2
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.肾移植受者在未接触过病毒的情况下，对 mRNA SARS-CoV-2 BNT162b2 疫苗的体液反应降低。
Am J Transplant. 2021 Aug;21(8):2719-2726. doi: 10.1111/ajt.16615. Epub 2021 May 7.
3
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
4
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.COVID-19 疫苗接种准备与自身免疫性疾病中的抗 CD20 耗竭疗法。
Clin Exp Immunol. 2020 Nov;202(2):149-161. doi: 10.1111/cei.13495. Epub 2020 Aug 1.
Zotero 插件